In-Licensing

We are interested to acquire production technologies of therapeutic monoclonal antibodies, such as Rituximab and Infliximab. Our client is an established company looking to increase its product portfolio by in-licensing or acquiring new products.

Our client is specifically looking to acquire the therapeutic monoclonal antibodies, such as Rituximab and Infliximab, as well as other products.

To discuss details, please contact us at info@bostontex.com.